General InformationBioLife Solutions is a publicly traded biotech company based in Bothell, Washington, with approximately 250+ employees, founded in 1998, specializing in biopreservation technologies for cell and gene therapies.
Funding & FinancialsBioLife Solutions is publicly traded on NASDAQ under ticker BLFS; the company has generated significant revenue through product sales and strategic partnerships rather than traditional venture funding rounds.
Leadership & TeamCEO Michael Rice has led the company through its public market transition; the company has built a experienced executive team focused on commercialization of biopreservation solutions.
Recent ActivityRecent developments include expanded adoption of their CryoStor and HypoThermosol products by leading CAR-T and gene therapy manufacturers, with continued growth in cold chain logistics partnerships.